QuinStreet reported GAAP revenue of $262.1 million in Q4 FY2025 and Non-GAAP EPS of $0.25 in Q4 FY2025, Both non-GAAP EPS ($0.25) and GAAP revenue ($262.1 million) exceeded analyst estimates. Auto ...

QuinStreet, Inc. (Nasdaq: QNST), a leader in performance marketplaces and technologies for the financial services and home services industries, today announced financial results for the fiscal fourth ...

Detailed price information for Nuvista Energy Ltd (NVA-T) from The Globe and Mail including charting and trades.

Key Points GAAP revenue for Q2 2025 exceeded analyst estimates, reaching $1.23 billion compared to expectations of $1.21 billion. Advertising revenue fell 9.0%, mainly due to lower political ...

Discover why Fannie Mae Series S & T preferreds offer double-digit yields, deep discounts, and lower risk. Unlock potential ...

Imperial Metals Corporation (the "Company" or "Imperial") (TSX:III) reports financial results for the three and six months ended June 30 ...

VANCOUVER, British Columbia, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Imperial Metals Corporation (the “Company” or “Imperial”) (TSX:III) reports financial results for the three and six months ended June 30, ...

Key Points Revenue (GAAP) grew to $550.8 million, surpassing analyst estimates by $13.45 million (GAAP) and rising 15.2% from the prior year. Earnings per share (Non-GAAP) missed estimates, coming in ...

Raffield provided an update that “Centerra reported yesterday that they had encountered lower-than-expected gold grades… and reduce [d] their 2025 gold production guidance to 145,000 to 165,000 ounces ...

Second quarter 2025 net loss of $147.9 million, or basic loss per common share of $1.70 per share Second quarter 2025 Adjusted EBITDA with Tax Attributes of $76.5 ...

PARSIPPANY, NJ, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Interpace Biosciences, Inc. (“Interpace” or the “Company”) (OTCQX: IDXG) today announced financial results for the second quarter ended June 30, 2025 ...

BSY tops Q2 earnings and revenue estimates with strong global growth, but shares slip 3.21% despite upbeat guidance.